- Ticker
- ADTX
- Price
- 3.11
- Stock movement up
- +- (%)
- Company name
- Aditxt Inc.
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 333.99K
- Ent value
- -2.43M
- Price/Sales
- 0.39
- Price/Book
- 0.03
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -90.85%
- 3 year return
- -91.89%
- 5 year return
- -
- 10 year return
- -
Last updated: 2024-04-08
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
ADTX does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.39 |
| Price to Book | 0.03 |
| EV to Sales | -2.84 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 107.39K |
| EPS (TTM) | -1214.62 |
| FCF per share (TTM) | -690.96 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 853.15K |
| Gross profit (TTM) | 178.56K |
| Operating income (TTM) | -41.27M |
| Net income (TTM) | -43.52M |
| EPS (TTM) | -1.21K |
| EPS (1y forward) | -65.60 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 20.93% |
| Operating margin (TTM) | -4837.80% |
| Profit margin (TTM) | -5100.99% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 9.24M |
| Net receivables | 1.25M |
| Total current assets | 12.62M |
| Goodwill | 0.00 |
| Intangible assets | 133.75K |
| Property, plant and equipment | 0.00 |
| Total assets | 19.18M |
| Accounts payable | 2.71M |
| Short/Current long term debt | 3.56M |
| Total current liabilities | 4.37M |
| Total liabilities | 6.49M |
| Shareholder's equity | 12.69M |
| Net tangible assets | 12.56M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -24.36M |
| Capital expenditures (TTM) | 393.31K |
| Free cash flow (TTM) | -24.76M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -342.82% |
| Return on Assets | -226.90% |
| Return on Invested Capital | -307.69% |
| Cash Return on Invested Capital | -175.03% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 3.12 |
| Daily high | 3.15 |
| Daily low | 3.00 |
| Daily Volume | 156K |
| All-time high | 15200.00 |
| 1y analyst estimate | 160.00 |
| Beta | 1.60 |
| EPS (TTM) | -1214.62 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ADTX | S&P500 | |
| Current price drop from All-time high | -99.98% | -0.85% |
| Highest price drop | -99.98% | -56.47% |
| Date of highest drop | 27 Mar 2024 | 9 Mar 2009 |
| Avg drop from high | -85.40% | -11.35% |
| Avg time to new high | 316 days | 13 days |
| Max time to new high | 923 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
333.99K
Marketcap category
Small-cap
Description
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.
Employees
58
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page